The sleep impact from Reta varies considerably - the people who report no change or improvement are likely not running at doses that push the glucagon component hard, since glucagon receptor activation is the pathway most associated with stimulatory side effects. Cortisol and resting heart rate tend to be the more consistent signals of whether glucagon activation is too high for a given person. Starting at the lower end of the dose range and measuring resting HR over the first 3-4 weeks is the cleaner way to calibrate before bumping up. Existing sleep difficulty can mask the Reta contribution, making it harder to isolate - a wearable with a consistent baseline helps.